The person was administered the vaccine in January last year as part of a mid-stage study. Novavax said on Monday it had ...
On NVAX's third-quarter earnings call, investors will likely seek updates on management???s ongoing discussions with the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback